Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240M
-
Number of holders
-
147
-
Total shares
-
82.8M
-
Shares change
-
+7.04M
-
Total reported value, excl. options
-
$990M
-
Value change
-
+$84.5M
-
Put/Call ratio
-
0.46
-
Number of buys
-
83
-
Number of sells
-
-68
-
Price
-
$11.95
Significant Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q2 2024
filings reported holding CLBT - Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share as of Q2 2024.
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.8M shares
of 240M outstanding shares and own 34.46% of the company stock.
Largest 10 shareholders include True Wind Capital Management, L.P. (13.4M shares), Clal Insurance Enterprises Holdings Ltd (7.65M shares), MORGAN STANLEY (6.99M shares), Nine Ten Capital Management LLC (3.92M shares), CROSSLINK CAPITAL INC (3.59M shares), Phoenix Holdings Ltd. (2.84M shares), ACADIAN ASSET MANAGEMENT LLC (2.76M shares), Voss Capital, LP (2.54M shares), Greenhaven Road Investment Management, L.P. (2.47M shares), and FMR LLC (2.38M shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.